Quoin Pharmaceuticals (QNRX) Receivables (2017 - 2020)

Quoin Pharmaceuticals has disclosed Receivables across 3 years of filings, most recently posting $88000.0 for Q4 2020.

• In Q4 2020, Receivables changed N/A year-over-year to $88000.0; the TTM figure through Dec 2020 stood at $88000.0 (changed N/A YoY), while the FY2020 annual figure was $88000.0, down 35.29% from the prior year.
• Receivables came in at $88000.0 for Q4 2020 at Quoin Pharmaceuticals, down from $226000.0 in the prior quarter.
• In the past five years, Receivables ranged from a high of $253000.0 in Q4 2017 to a low of $88000.0 in Q4 2020.
• Average Receivables over 3 years is $189000.0, with a median of $226000.0 recorded in 2018.
• The largest YoY upside for Receivables was 10.67% in 2018 against a maximum downside of 10.67% in 2018.
• Over 3 years, Receivables stood at $253000.0 in 2017, then declined by 10.67% to $226000.0 in 2018, then tumbled by 61.06% to $88000.0 in 2020.
• Per Business Quant data, the three most recent Receivables figures were $88000.0 in Q4 2020, $226000.0 in Q4 2018, and $253000.0 in Q4 2017.